Blepharitis surgery: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
[[Surgical|Surgical intervention]] is not the first-line treatment option for patients with blepharitis. | [[Surgical|Surgical intervention]] is not the first-line treatment option for patients with blepharitis.<ref name="pmid24043929">{{cite journal| author=Qiao J, Yan X| title=Emerging treatment options for meibomian gland dysfunction. | journal=Clin Ophthalmol | year= 2013 | volume= 7 | issue= | pages= 1797-803 | pmid=24043929 | doi=10.2147/OPTH.S33182 | pmc=3772773 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24043929 }} </ref><ref name="pmid21450919">{{cite journal| author=Geerling G, Tauber J, Baudouin C, Goto E, Matsumoto Y, O'Brien T et al.| title=The international workshop on meibomian gland dysfunction: report of the subcommittee on management and treatment of meibomian gland dysfunction. | journal=Invest Ophthalmol Vis Sci | year= 2011 | volume= 52 | issue= 4 | pages= 2050-64 | pmid=21450919 | doi=10.1167/iovs.10-6997g | pmc=3072163 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21450919 }} </ref> | ||
<ref name="pmid21450919">{{cite journal| author=Geerling G, Tauber J, Baudouin C, Goto E, Matsumoto Y, O'Brien T et al.| title=The international workshop on meibomian gland dysfunction: report of the subcommittee on management and treatment of meibomian gland dysfunction. | journal=Invest Ophthalmol Vis Sci | year= 2011 | volume= 52 | issue= 4 | pages= 2050-64 | pmid=21450919 | doi=10.1167/iovs.10-6997g | pmc=3072163 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21450919 }} </ref> | |||
==Surgery== | ==Surgery== | ||
Surgical intervention is usually reserved for the patients with complications | Surgical intervention for blepharitis is usually reserved for the patients with complications, such as [[chalazion]], [[entropion]], [[ectropion]], or horizontal eyelid laxity.<ref name="pmid24043929">{{cite journal| author=Qiao J, Yan X| title=Emerging treatment options for meibomian gland dysfunction. | journal=Clin Ophthalmol | year= 2013 | volume= 7 | issue= | pages= 1797-803 | pmid=24043929 | doi=10.2147/OPTH.S33182 | pmc=3772773 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24043929 }} </ref> | ||
===Lipiflow sysytem=== | |||
LipiFlow, thermal pulsation system gave rise to significant improvement in both signs (based on tear break-up time, corneal fluorescein staining) and symptoms (based on Ocular Surface Disease Index and standard patient evaluation of eye dryness scores).<ref name="pmid22222996">{{cite journal| author=Lane SS, DuBiner HB, Epstein RJ, Ernest PH, Greiner JV, Hardten DR et al.| title=A new system, the LipiFlow, for the treatment of meibomian gland dysfunction. | journal=Cornea | year= 2012 | volume= 31 | issue= 4 | pages= 396-404 | pmid=22222996 | doi=10.1097/ICO.0b013e318239aaea | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22222996 }} </ref> | |||
===Intraductal Meibomian Gland Probing=== | ===Intraductal Meibomian Gland Probing=== | ||
Revision as of 18:24, 13 July 2016
|
Blepharitis Microchapters | |
|
Diagnosis | |
|---|---|
|
Treatment | |
|
Case Studies | |
|
Blepharitis surgery On the Web | |
|
American Roentgen Ray Society Images of Blepharitis surgery | |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Sara Mehrsefat, M.D. [2]
Overview
Surgical intervention is not the first-line treatment option for patients with blepharitis.[1][2]
Surgery
Surgical intervention for blepharitis is usually reserved for the patients with complications, such as chalazion, entropion, ectropion, or horizontal eyelid laxity.[1]
Lipiflow sysytem
LipiFlow, thermal pulsation system gave rise to significant improvement in both signs (based on tear break-up time, corneal fluorescein staining) and symptoms (based on Ocular Surface Disease Index and standard patient evaluation of eye dryness scores).[3]
Intraductal Meibomian Gland Probing
Invasive orifice penetration and intraductal probing seems to provide lasting rapid symptom relief for patients with posterior blepharitis with meibomian gland dysfunction (MGD).[4]
References
- ↑ 1.0 1.1 Qiao J, Yan X (2013). "Emerging treatment options for meibomian gland dysfunction". Clin Ophthalmol. 7: 1797–803. doi:10.2147/OPTH.S33182. PMC 3772773. PMID 24043929.
- ↑ Geerling G, Tauber J, Baudouin C, Goto E, Matsumoto Y, O'Brien T; et al. (2011). "The international workshop on meibomian gland dysfunction: report of the subcommittee on management and treatment of meibomian gland dysfunction". Invest Ophthalmol Vis Sci. 52 (4): 2050–64. doi:10.1167/iovs.10-6997g. PMC 3072163. PMID 21450919.
- ↑ Lane SS, DuBiner HB, Epstein RJ, Ernest PH, Greiner JV, Hardten DR; et al. (2012). "A new system, the LipiFlow, for the treatment of meibomian gland dysfunction". Cornea. 31 (4): 396–404. doi:10.1097/ICO.0b013e318239aaea. PMID 22222996.
- ↑ Maskin SL (2010). "Intraductal meibomian gland probing relieves symptoms of obstructive meibomian gland dysfunction". Cornea. 29 (10): 1145–52. doi:10.1097/ICO.0b013e3181d836f3. PMID 20622668.